Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "First Phase 3 Results From CARTITUDE-4 - Cilta-Cel vs. Standard of Care (PVd or DPd) in Lenalidomide-Refractory MM"

381 views
June 22, 2023
0 Comments
Login to view comments. Click here to Login
Hematology